<DOC>
	<DOCNO>NCT03060694</DOCNO>
	<brief_summary>The purpose study compare severity NAFLD diabetic patient non-diabetic patient .</brief_summary>
	<brief_title>Screening Diabetes Patients NAFLD With Controlled Attenuation Parameter Liver Stiffness Measurements</brief_title>
	<detailed_description>1 . Patient recruitment : eligible patient department endocrinology department gastroenterology encourage participate study . 2 . Non-diabetic patient admit department gastroenterology gastroenterological disease . If available , patient ' data collect control group . Each diabetic patient match non-diabetic patient factor age , gender BMI . 3 . Hepatic steatosis fibrosis diagnose via control attenuation parameter ( CAP ) liver stiffness measurement FibroScan ® , respectively . According meta-analysis individual patient data publish recently , CAP dB/m adjust deduct 10dB/m CAP value NAFLD/NASH patient , 10dB/m diabetes patient deducting/adding 4.4dB/m unit BMI above/below 25kg/m2 range 20-30kg/m2 . 4 . Regular laboratory test perform , include complete blood count , liver function , renal function , coagulation function , glycosylated hemoglobin , lipid metabolism , urine albumin/creatinine ratio , 24-hour urine albumin . 5 . Anthropometric data consist height , weight , body mass index ( weight kilogram divide square height meter ) waist circumference . 6 . The diabetic duration , diabetic complication , grade hypertension , history anti-diabetic drug gather medical record . 7 . The data collect via EpiData software . They input computer twice single researcher avoid type error . 8 . Site monitor audit : As project postgraduate thesis , study monitor audited school postgraduate . The research record check December , 2016 , mid-term inspection 9 . Statistical analysis plan : data summarize present use appropriate descriptive statistic . The normality continuous variable assess skewness statistic graphically normal probability plot . Patients characteristic without diabetes , diabetes group , without elevate CAP compare use independent test , Chi-square , Fisher 's exact test appropriate .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>≥18 year type 2 diabetic malignancy ; severe cardiovascular complication ; history chronic hepatitis ( hepatitis B C virus infection , autoimmune hepatitis , Wilson 's disease , hemachromatosis ) ; secondary cause fatty liver ( glucocorticoid , amiodarone , tamoxifen ) ; alcohol consuming ( 20grams per day male , 10 gram per day female ) ; hint type 1 diabetes ( ketoacidosis , ketonuria , use insulin within 1 year diagnosis )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Non-alcoholic Fatty Liver Disease</keyword>
	<keyword>Diabetes Mellitus , Type 2</keyword>
</DOC>